Eagle Pharmaceuticals Income Taxes 2013-2023 | EGRX

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Eagle Pharmaceuticals income taxes from 2013 to 2023. Income taxes can be defined as the total amount of income tax expense for the given period.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Eagle Pharmaceuticals income taxes from 2013 to 2023. Income taxes can be defined as the total amount of income tax expense for the given period.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$196.7B
Stryker (SYK)	$142.8B
Boston Scientific (BSX)	$132.8B
EssilorLuxottica (ESLOY)	$110.9B
Medtronic (MDT)	$105.8B
Haleon (HLN)	$44.2B
Lonza Group Ag (LZAGY)	$43.1B
GE HealthCare Technologies (GEHC)	$37.1B
ResMed (RMD)	$35B
Terumo (TRUMY)	$29.6B
Koninklijke Philips (PHG)	$24.2B
Zimmer Biomet Holdings (ZBH)	$21.2B
Insulet (PODD)	$18.9B
Baxter (BAX)	$15.5B
Smith & Nephew SNATS (SNN)	$11.2B
BellRing Brands (BRBR)	$10B
Bio-Rad Laboratories (BIO)	$9.4B
Demant (WILYY)	$8.3B
Lantheus Holdings (LNTH)	$6.5B
Haemonetics (HAE)	$4.1B
Prestige Consumer Healthcare (PBH)	$4.1B
ICU Medical (ICUI)	$4B
Perrigo (PRGO)	$3.7B
Envista Holdings (NVST)	$3.4B
Shandong Weigao Medical Polymer (SHWGF)	$3B
GN Store Nord (GNNDY)	$2.9B
QuidelOrtho (QDEL)	$2.8B
Neogen (NEOG)	$2.6B
LeMaitre Vascular (LMAT)	$2.3B
Green Thumb Industries (GTBIF)	$1.7B